DexCom Inc. closed 51.60% short of its 52-week high of $139.24, which the company achieved on April 25th.

Dexcom has announced that the U.S. Food and Drug Administration has cleared its G7 15 Day Continuous Glucose Monitoring ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of $107.00. The company’s shares closed la ...

BTIG lowered the firm’s price target on DexCom (DXCM) to $107 from $120 and keeps a Buy rating on the shares as part of a broader research note ...

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

Once-weekly basal insulin combined with an intermittently scanned continuous glucose monitor reduced HbA1c and improved time ...

The global demographic shift is reshaping healthcare demand, driving long-term investment in pharmaceuticals, medical devices ...

Satio and Nanowear today announced that they partnered to advance patient-friendly, home-based diagnostic and therapeutic ...

Mackenzie McKee took to Instagram to share the highs and lows of her pregnancy with twins.On April 8, McKee, 30, who is ...

Pfizer said Monday it's scrapping development of its daily weight-loss pill, danuglipron, after a patient experienced a liver injury.

High school life is a fragile juggling act of managing painstaking amounts of schoolwork, meeting the demands of ...